<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Andrejko KL</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Despite lower circulation of influenza virus throughout 2020-2022 during the COVID-19 pandemic, seasonal influenza vaccination has remained a primary tool to reduce influenza-associated illness and death. The relationship between the decision to receive a COVID-19 vaccine and/or an influenza vaccine is not well understood.&lt;h4>Methods&lt;/h4>We assessed predictors of receipt of 2021-2022 influenza vaccine in a secondary analysis of data from a case-control study enrolling individuals who received SARS-CoV-2 testing. We used mixed effects logistic regression to estimate factors associated with receipt of seasonal influenza vaccine. We also constructed multinomial adjusted marginal probability models of being vaccinated for COVID-19 only, seasonal influenza only, or both as co</pubmed_abstract><journal>Vaccine</journal><pagination>S0264-410X(22)01578-X</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9780637</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021-2022 influenza season.</pubmed_title><pmcid>PMC9780637</pmcid><pubmed_authors>Watt JP</pubmed_authors><pubmed_authors>Jain S</pubmed_authors><pubmed_authors>Andrejko KL</pubmed_authors><pubmed_authors>Myers JF</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Lewnard JA</pubmed_authors><pubmed_authors>California COVID-19 Case-Control Study Team</pubmed_authors><pubmed_authors>Fukui N</pubmed_authors><pubmed_authors>Murray EL</pubmed_authors><pubmed_authors>Openshaw J</pubmed_authors><pubmed_authors>Pry JM</pubmed_authors><pubmed_authors>Hoover C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021-2022 influenza season.</name><description>&lt;h4>Background&lt;/h4>Despite lower circulation of influenza virus throughout 2020-2022 during the COVID-19 pandemic, seasonal influenza vaccination has remained a primary tool to reduce influenza-associated illness and death. The relationship between the decision to receive a COVID-19 vaccine and/or an influenza vaccine is not well understood.&lt;h4>Methods&lt;/h4>We assessed predictors of receipt of 2021-2022 influenza vaccine in a secondary analysis of data from a case-control study enrolling individuals who received SARS-CoV-2 testing. We used mixed effects logistic regression to estimate factors associated with receipt of seasonal influenza vaccine. We also constructed multinomial adjusted marginal probability models of being vaccinated for COVID-19 only, seasonal influenza only, or both as co</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-04T08:25:14.544Z</modification><creation>2025-02-19T00:47:41.706Z</creation></dates><accession>S-EPMC9780637</accession><cross_references><pubmed>36585281</pubmed><doi>10.1016/j.vaccine.2022.12.052</doi></cross_references></HashMap>